Asthma mortality in New Zealand: a two year national study
- PMID: 2859567
Asthma mortality in New Zealand: a two year national study
Abstract
The epidemic of deaths from bronchial asthma in New Zealand was investigated by a two-year national review of all deaths of persons under 70 years where "asthma" appeared in part I of a death certificate or in a coroner's report of cause of death. Information about the patients, the characteristics and management of their asthma and the circumstances of the fatal episode was obtained by interviewing relatives and general practitioners and perusal of hospital records. The reviewing panel of the asthma task force of the Medical Research Council considered 271 of the 342 deaths studied were due to asthma. A high national asthma mortality rate (5.1 per 100 000) was confirmed, with rates for Maoris (18.9) and Pacific Islanders (9.4) considerably higher than that for Europeans (3.4 per 100 000). After standardising for age and ethnic groups, there remained a threefold variation in mortality rates among health districts suggesting regional differences in prevalence, severity or management of asthma. No single cause for these high mortality rates was found. One-quarter of the deaths occurred in patients who had had previous life threatening attacks. Excessive use of bronchodilator drugs did not account for the high mortality rates, but inappropriate prolonged use of a home nebuliser may have delayed institution of other therapy in a few cases.
Similar articles
-
Why are deaths from asthma increasing?Eur J Respir Dis Suppl. 1986;147:175-81. Eur J Respir Dis Suppl. 1986. PMID: 2876911 Review.
-
Worldwide trends in asthma mortality.Bull Int Union Tuberc Lung Dis. 1991 Jun-Sep;66(2-3):79-83. Bull Int Union Tuberc Lung Dis. 1991. PMID: 1684522
-
Death from asthma in Auckland: circumstances and validation of causes.N Z Med J. 1984 Dec 12;97(769):845-8. N Z Med J. 1984. PMID: 6595566
-
Asthma mortality in the Danish child population: risk factors and causes of asthma death.Pediatr Pulmonol. 2003 Aug;36(2):142-7. doi: 10.1002/ppul.10305. Pediatr Pulmonol. 2003. PMID: 12833494
-
[Round Table: Severe asthma in pediatrics: treatment of acute crises].Allergol Immunopathol (Madr). 1999 Mar-Apr;27(2):53-62. Allergol Immunopathol (Madr). 1999. PMID: 10354007 Review. Spanish.
Cited by
-
Beta-agonists and asthma mortality. What have we learned, what questions remain?Drugs. 1990 Nov;40(5):653-6. doi: 10.2165/00003495-199040050-00001. Drugs. 1990. PMID: 1981353 Review. No abstract available.
-
Investigating asthma deaths among children and young adults: Michigan Asthma Mortality Review.Public Health Rep. 2007 May-Jun;122(3):373-81. doi: 10.1177/003335490712200311. Public Health Rep. 2007. PMID: 17518309 Free PMC article.
-
Use of anti-asthma drugs in New Zealand.Thorax. 1987 Sep;42(9):670-5. doi: 10.1136/thx.42.9.670. Thorax. 1987. PMID: 3686458 Free PMC article.
-
Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths.Thorax. 1993 Nov;48(11):1105-9. doi: 10.1136/thx.48.11.1105. Thorax. 1993. PMID: 8296252 Free PMC article.
-
Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking.J Pharmacokinet Biopharm. 1994 Dec;22(6):469-80. doi: 10.1007/BF02353790. J Pharmacokinet Biopharm. 1994. PMID: 7473077 Clinical Trial.